The Royal Wolverhampton Hospitals Nhs Trust

This study will test whether artificial intelligence-enhanced 3D and 2D echocardiography (ultrasound) can detect heart damage caused by chemotherapy as accurately as cardiac MRI. Researchers will compare these AI methods with standard ultrasound and MRI in 120 adults who have rec…

This study tests a new device designed to prevent surgical swabs (small towels used to soak up blood) from being accidentally left inside a patient during childbirth. About 70 women giving birth will take part, and the device will be used during cesarean sections or vaginal repai…

This study creates a national registry for people with vitiligo in the UK. It will collect information on treatment safety and effectiveness from 30 patients in secondary care. No new drugs or therapies are being tested—just data gathering to guide future care.

This study looks at how anxiety, depression, and stress might cause advanced IBD treatments to stop working. Researchers will ask 450 people with IBD to fill out questionnaires about their mental health while they receive regular infusions. The goal is to understand if mental hea…

This study will test a digital health app called Albert Health that helps adults manage a newly inserted PEG feeding tube. About 50 patients and their carers will use the app and give feedback on how easy and helpful it is. The goal is to see if the app works well enough to be te…

This study tests a new device designed to help surgical teams keep accurate counts of items used during surgery, reducing the risk of leaving something inside a patient. About 30 adults having planned surgery at an NHS hospital will take part. Researchers will gather feedback thr…

This study will review medical records of 300 UK patients with newly diagnosed multiple myeloma who cannot have a stem cell transplant and are treated with a three-drug combination (daratumumab, lenalidomide, and dexamethasone). The goal is to see how well this therapy works in e…

This study surveys doctors and nurses to see how they decide when to refer patients with chronic lymphocytic leukemia (CLL) to specialists. The goal is to find differences in care across the West Midlands region and suggest ways to make referrals fairer and more consistent. About…